Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ovarian cancer
ovarian cancer
Carrick bags ex-Onyx cancer drug, plans pivotal trials
Fierce Biotech
Thu, 10/11/18 - 09:27 am
ovarian cancer
Carrick
Onyx
CT900
Study cracks open the secrets of the cancer-causing BRCA1 gene
Stat
Wed, 09/12/18 - 07:20 pm
Myriad Genetics
genetic testing
BRCA1
R&D
breast cancer
ovarian cancer
Aravive Biologics’ Treatment For Platinum-Resistant Recurrent Ovarian Cancer Receives Fast Track Designation
CP Wire
Mon, 08/20/18 - 09:58 am
Aravive Biologics
AVB-S6-500
ovarian cancer
platinum-resistant ovarian cancer
Aravive Biologics’ Treatment For Platinum-Resistant Recurrent Ovarian Cancer Receives Fast Track Designation
Mon, 08/20/18 - 09:44 am
Aravive Biologics
AVB-S6-500
ovarian cancer
platinum-resistant ovarian cancer
Clovis Starts Ph III Trial with Combination of Rubraca and Opdivo in Advanced Ovarian Cancer
CP Wire
Wed, 08/8/18 - 09:35 am
Clovis Oncology
clinical trials
Bristol-Myers Squibb
Opdivo
ovarian cancer
Clovis Starts Ph III Trial with Combination of Rubraca and Opdivo in Advanced Ovarian Cancer
Wed, 08/8/18 - 09:01 am
Clovis Oncology
Rubraca
Opdivo
ovarian cancer
Tesaro CEO Says Its Drug 'Will Get There' — Analysts Strongly Disagree
Investors.com
Sat, 08/4/18 - 11:51 am
Tesaro
Zejula
ovarian cancer
Johnson & Johnson Hit by $4.7 Billion Jury Verdict in Ovarian Cancer Case
TheStreet.com
Fri, 07/13/18 - 09:38 am
JNJ
ovarian cancer
AstraZeneca, Merck eye wider cancer drug use after study success
Yahoo/Reuters
Wed, 06/27/18 - 09:42 am
AstraZeneca
Merck
Lynparza
ovarian cancer
Arcus Biosciences and Infinity Pharmaceuticals Partner to Evaluate Triple-Combination Therapy in Breast and Ovarian Cancer
CP Wire
Tue, 06/26/18 - 09:43 am
Arcus Biosciences
Infinity Pharmaceuticals
drug development
IPI-549
AB928
AB122
breast cancer
ovarian cancer
Arcus Biosciences and Infinity Pharmaceuticals Partner to Evaluate Triple-Combination Therapy in Breast and Ovarian Cancer
Tue, 06/26/18 - 09:23 am
Arcus Biosciences
Infinity Pharmaceuticals
breast cancer
ovarian cancer
BeiGene Initiates Phase 3 Trial of Pamiparib as Maintenance Therapy in Patients with Ovarian Cancer
CP Wire
Thu, 05/17/18 - 12:03 pm
BeiGene
pamiparib
ovarian cancer
China
clinical trials
BeiGene Initiates Phase 3 Trial of Pamiparib as Maintenance Therapy in Patients with Ovarian Cancer
Thu, 05/17/18 - 09:53 am
BeiGene
pamiparib
ovarian cancer
ImmunoGen Gets Good News From Interim Analysis of Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
CP Wire
Fri, 04/27/18 - 01:18 pm
Immunogen
mirvetuximab soravtansine
ovarian cancer
platinum-resistant ovarian cancer
ImmunoGen Gets Good News From Interim Analysis of Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
Fri, 04/27/18 - 01:19 pm
Immunogen
mirvetuximab soravtansine
ovarian cancer
platinum-resistant ovarian cancer
Boston Scientific acquires NVision Medical in $275m deal
Mass Device
Mon, 04/16/18 - 10:33 am
Boston Scientific
NVision Medical
M&A
devices
diagnostics
ovarian cancer
Rubraca (rucaparib) Approved in the U.S. as Maintenance Treatment of Recurrent Ovarian Cancer
CP Wire
Fri, 04/6/18 - 02:46 pm
Clovis Oncology
Rubraca
ovarian cancer
Rubraca (rucaparib) Approved in the U.S. as Maintenance Treatment of Recurrent Ovarian Cancer
Fri, 04/6/18 - 02:45 pm
Clovis Oncology
Rubraca
ovarian cancer
Tesaro Wants a Stronger Grip in Ovarian Cancer
Yahoo/Motley Fool
Tue, 03/27/18 - 10:10 pm
Tesaro
AstraZeneca
Clovis Oncology
ovarian cancer
Zejula
Rubraca
Lynparza
AstraZeneca Goes Up Against 2 Cancer Upstarts
Motley Fool
Sat, 03/10/18 - 09:17 am
AstraZeneca
Clovis Oncology
PARP inhibitors
Lynparza
ovarian cancer
breast cancer
Rubraca
Zejula
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »